首页> 美国卫生研究院文献>Toxicological Research >Subacute Oral Toxicity and Bacterial Mutagenicity Study of a Mixture of Korean Red Ginseng (Panax ginseng C.A. Meyer) and Salvia plebeia R. Br. Extracts
【2h】

Subacute Oral Toxicity and Bacterial Mutagenicity Study of a Mixture of Korean Red Ginseng (Panax ginseng C.A. Meyer) and Salvia plebeia R. Br. Extracts

机译:韩国红参(Panax ginseng C.A. Meyer)和丹参(Salvia plebeia R. Br。)混合物的亚急性口服毒性和细菌致突变性研究。提取物

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

As various populations are rapidly becoming an aging society worldwide and interest in health issues has increased, demand for functional foods including herbal products has increased markedly to maintain a healthy state which has led to safety issues about their intake as an inevitable result. The objective of this study was to identify the safety profile of a Korean red ginseng and Salvia plebeia R. Br. extract mixture (KGC-03-PS) which is a valuable ingredient that can be used as a functional food. In the present study, the subacute oral toxicity and bacterial reverse mutagenicity of KGC-03-PS were evaluated. Sprague Dawley rats were administered KGC-03-PS orally for 28 days by gavage. Daily KGC-03-PS dose concentrations were 0, 500, 1,000, or 2,000 mg/kg body weight (bw) per day. Bacterial reverse mutation test with KGC-03-PS dose levels ranging from 312.5 to 5,000 μg/plate was carried out by OECD test guideline No. 471. Five bacterial strains (Salmonella typhimurium TA98, TA100, TA1535, TA1537, and Escherichia coli WP2) were tested in the presence or absence of metabolic activation by plate incorporation method. There were no toxicological effects related with test substance in the clinical evaluation of subacute oral toxicity test including clinical signs, body weight, and food consumption. Moreover, no toxicological changes related to KGC-03-PS were observed in the hematological and serum biochemical characteristics as well as in the pathological examinations, which included organ weight measurements and in the gross- or histopathological findings. KGC-03-PS did not induce an increase in the number of revertant colonies in all bacterial strains of the bacterial reverse mutation test. The no-observed-adverse-effect level of KGC-03-PS is greater than 2,000 mg/kg bw/day, and KGC-03-PS did not induce genotoxicity related to bacterial reverse mutations under the conditions used in this study.
机译:随着世界各地各种人群迅速成为老龄化社会并且对健康问题的兴趣增加,对包括草药产品在内的功能性食品的需求显着增加,以保持健康状态,这不可避免地导致了有关其摄入的安全问题。这项研究的目的是确定高丽红参和丹参的安全性。提取物混合物(KGC-03-PS)是一种有价值的成分,可以用作功能性食品。在本研究中,评估了KGC-03-PS的亚急性口服毒性和细菌反向诱变性。通过管饲法将Sprague Dawley大鼠口服KGC-03-PS,持续28天。每日KGC-03-PS剂量浓度为每天0、500、1,000或2,000 mg / kg体重(bw)。通过OECD测试准则471进行KGC-03-PS剂量水平范围为312.5至5,000μg/板的细菌反向突变测试。五种细菌菌株(鼠伤寒沙门氏菌TA98,TA100,TA1535,TA1537和大肠杆菌WP2)通过板结合法检测是否存在代谢活化。在亚急性口服毒性试验的临床评估中,与临床试验物质,体重和食物消耗量无关的毒理学影响没有。此外,在血液学和血清生化特性以及病理检查中未观察到与KGC-03-PS相关的毒理学变化,其中包括器官重量测量以及总体或组织病理学发现。在细菌反向突变试验的所有细菌菌株中,KGC-03-PS均未诱导其回复菌落数量的增加。在本研究中使用的条件下,KGC-03-PS的未观察到的不良反应水平大于2,000 mg / kg bw /天,并且KGC-03-PS不会引起与细菌反向突变相关的遗传毒性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号